BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37581694)

  • 21. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
    Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
    World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
    Chen J; Wang P; Lv K; Zhou W
    Diagn Pathol; 2021 Nov; 16(1):108. PubMed ID: 34801052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system.
    Wiedenmann B; John M; Ahnert-Hilger G; Riecken EO
    J Mol Med (Berl); 1998 Aug; 76(9):637-47. PubMed ID: 9725766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of pancreatic acinar differentiation in gastric adenocarcinoma: report of a case and immunohistochemical study of 111 additional cases.
    Lee H; Tang LH; Veras EF; Klimstra DS
    Am J Surg Pathol; 2012 Mar; 36(3):402-8. PubMed ID: 22082608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric neuroendocrine tumour, atrophic gastritis and autoimmune haemolytic anaemia: a case report and review.
    Papakonstantinou IP; Karakousis ND; Andreadis EA
    Scott Med J; 2019 Nov; 64(4):154-158. PubMed ID: 31403382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature.
    Zhang D; Li P; Szankasi P; Liao X
    Pathol Res Pract; 2020 Jul; 216(7):152997. PubMed ID: 32534704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Composite glandular and endocrine tumors of the stomach with pancreatic acinar differentiation.
    Jain D; Eslami-Varzaneh F; Takano AM; Ayer U; Umashankar R; Muller R; Klimstra DS
    Am J Surg Pathol; 2005 Nov; 29(11):1524-9. PubMed ID: 16224221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
    Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
    World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
    Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
    Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms.
    Nassereddine H; Chicaud M; Rebah K; Théou-Anton N; Sautet A; Dermer J; Couvelard A
    Endocr Pathol; 2021 Dec; 32(4):517-523. PubMed ID: 34019237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
    Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
    Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
    Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
    Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation.
    Fujii T; Kawai T; Saito K; Hishima T; Hayashi Y; Imura J; Hironaka M; Hosoya Y; Koike M; Fukayama M
    Pathol Int; 1999 Nov; 49(11):968-73. PubMed ID: 10594843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
    Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
    [No Abstract]   [Full Text] [Related]  

  • 38. New molecular aspects for the diagnosis and treatment of neuroendocrine gastroenteropancreatic tumors.
    Wiedenmann B; Ahnert-Hilger G; Kvols LK; Riecken EO
    Ann N Y Acad Sci; 1994 Sep; 733():515-25. PubMed ID: 7978902
    [No Abstract]   [Full Text] [Related]  

  • 39. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary.
    Iyer R; Hatoum H
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):17-9. PubMed ID: 27168109
    [No Abstract]   [Full Text] [Related]  

  • 40. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
    Kawasaki K; Fujii M; Sato T
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.